Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print A new cellular pathway linked to cancer is identified by NYU researchers

A new cellular pathway linked to cancer is identified by NYU researchers

July 25, 2008

In the life of a cell, the response to DNA damage determines whether the cell is fated to pause and repair itself, commit suicide, or grow uncontrollably, a route leading to cancer. In a new study, published in the July 25th issue of Cell, scientists at NYU Langone Medical Center have identified a way that cells respond to DNA damage through a process that targets proteins for disposal. The finding points to a new pathway for the development of cancer and suggests a new way of sensitizing cancer cells to treatment.

"One of the major messages of this study is that we have a new pathway that responds to DNA damage," says Michele Pagano, M.D., the May Ellen and Gerald Jay Ritter Professor of Oncology and Professor of Pathology at NYU School of Medicine, who was recently appointed a Howard Hughes Medical Institute Investigator. "It is already known that the three major protein players in this pathway are deregulated in human cancers, so deregulation of this pathway is probably going to contribute to tumorigenesis (the development of cancer)."




DNA damage can be caused by carcinogens in the environment, errors in DNA replication, or glitches in the cellular machinery caused by aging, among other factors. If a cell detects DNA damage when it is about to divide, it activates the so-called G2 checkpoint, a pause button that allows the cell time to correct the problem before cell division, the process whereby a cell makes two copies of itself. The cell maintains a paused state based on a series of proteins, a pathway, that work together like gears in a machine. Some are switched on and others are turned off (often by degradation) to maintain the checkpoint.

In addition to the new pathway's association with cancer, it suggests a potentially new way to sensitize cells to chemotherapy, says Dr. Pagano. Tumor cells already have a less efficient checkpoint because of defects in other regulatory pathways. Up to 60% of cancers, for example, have mutations in p53, a tumor suppressor gene and G2 checkpoint regulator that operates in a separate pathway.

Inhibiting this new pathway with a drug could make cancer cells especially vulnerable to DNA damage, causing cancerous cells to die rather than pausing to correct the problem, Dr. Pagano says. Unlike cancer cells, which already have a less efficient checkpoint, normal cells have a fully functioning G2 checkpoint and divide less frequently, sparing them from drug-induced cell death.

The central player in this pathway is the protein complex called APC/C, which is involved in multiple aspects of cell regulation through a trash disposal system that shreds proteins. In response to DNA damage, the cell targets Cdc14B, an enzyme that rips phosphate groups off of other proteins, to APC/C, an action which turns on the shredder. Once APC/C is turned on, it tags its target, Plk1, for disposal. If Plk1 remains active, the cell will continue to divide. Unlike the G2 checkpoint pathways that have been previously described, the researchers believe this one is "ancient" because it is evolutionarily conserved in organisms from yeast to humans.

According to the study, the deregulation of these three pathway components (Cdc14B, APC/C, and Plk1) in cancer cells correlates with lower survival rates in patients. Researchers will need to perform further studies to determine how these proteins are altered in cancer. Some of the effect might be due to changes in the levels of proteins expressed, but it is currently unknown whether mutations to these proteins might also play a role.

NYU Langone Medical Center / New York University School of Medicine



Related Cellular Pathway News Articles Cellular Pathway News and Current Cellular Pathway Events RSS Cellular Pathway News and Current Cellular Pathway Events RSS
Loss of sleep, even for a single night, increases inflammation in the body
Loss of sleep, even for a few short hours during the night, can prompt one's immune system to turn against healthy tissue and organs.

Stopping unwanted cell death: Implications for drug discovery
Research published in Nature Chemical Biology reveals that three specific inhibitors of a cell death pathway, termed necroptosis, all target and inhibit RIP1 kinase, a protein that can direct cells into necrosis.

MIT applies engineering approach to studying biological pathways
An MIT team has used an engineering approach to show that complex biological systems can be studied with simple models developed by measuring what goes into and out of the system.

2 different neural pathways regulate loss and regain of consciousness during general anesthesia
University of Pennsylvania School of Medicine researchers have answered long-running questions about the way that anesthetics act on the body, by showing that the cellular pathway for emerging from anesthesia is different from the one that drugs take to put patients to sleep during operations.

MIT links gene to cholesterol
MIT researchers have discovered a link between a gene believed to promote long lifespan and a pathway that flushes cholesterol from the body.

Breakthrough developments in rheumatoid arthritis reported
Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis.

Estrogen protects liver after traumatic injury
Researchers have identified the receptor pathway used by estrogen to decrease liver injury after trauma and hemorrhage.

Mayo Clinic Cancer Center — individualizing treatment for multiple myeloma patients
Researchers at Mayo Clinic Cancer Center, in cooperation with industry partners, have, for the first time, identified tumor specific alterations in the cellular pathway by which the multiple myeloma drug bortezomib (Velcade) works, and they have identified nine new genetic mutations in cancer cells that should increase a patient's chance of responding to the agent.

Parkinson's Disease Mechanism Discovered
Howard Hughes Medical Institute researchers have pinpointed defects in a critical cellular pathway that can lead to the death of dopamine-producing nerve cells and ultimately symptoms of Parkinson's disease.

Second low-oxygen pathway hints at cancer, cardiovascular disease physiology
Researchers at the University of Pennsylvania School of Medicine have identified a second molecular pathway that promotes cell survival in low-oxygen conditions.
More Cellular Pathway News Articles


Dietary Modulation of Cell Signaling Pathways (Oxidative Stress and Disease)

A comprehensive review of recent research findings, this book focuses on nutrient-gene interactions and the intracellular signaling network. Comprehensively covering dietary modulation of cell signaling, leading experts address the dietary modulation of particular gene expression systems. The book highlights the underlying molecular and cellular mechanisms that involve upstream signaling...



Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development) (Cancer Drug Discovery and Development)

Cancer chemotherapy can be traced back to the 1940 s and since then the world has witnessed the discovery and the important application of several new drugs. The successes of combination chemotherapy suggested that all cancers can be treated provided that the correct combination of drugs at the correct doses and correct intervals are established. However, with time, tumor cells develop mechanisms...



Cancer Stem Cells: Novel Concepts and Prospects for Tumor Therapy (Ernst Schering Foundation Symposium Proceedings)

Cancer stem cells werehave originally been identified in leukemia and later in several solid tumor types. They have very different properties from the bulk of the tumor, as they divide much more slowly and have very efficient drug- resistance mechanisms. Current treatments might largely spare cancer stem cells, thus leading to tumor recurrence and metastasis. The recent identification of growth...



Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases

As our understanding of apoptotic pathway expands, we are coming to realize the great potential of utilizing this pathway to treat diseases such as cancer. The book attempts to review, summarize, and speculate on the apoptotic pathways, how are they regulated and how targeted therapies are being used to treat a wide variety of diseases. Special emphasis is placed on cancer since new treatments...



Bone Morphogenetic Proteins: From Local to Systemic Therapeutics (Progress in Inflammation Research) (Progress in Inflammation Research) (Progress in Inflammation Research)

Tissue engineering is gaining interest as it is applied for regeneration of organs to attain their lost function. Although resorbable scaffolds and progenitor cell types are required principles to engineer a functional tissue locally, the inductive signal is a prerequisite to trigger the growth and differentiation of responding cells in space and time. Bone morphogenetic proteins (BMPs), also...



Protein Condensation: Kinetic Pathways to Crystallization and Disease
by James D. Gunton, Andrey Shiryayev, Daniel L. Pagan

The quest to understand the condensation of proteins from solutions is a rapidly evolving field. The purpose of this book is to bring to an interdisciplinary audience the state-of-the-art in current research. The first part of the book deals with issues related to the production of high quality protein crystals from solution. Since protein function is determined by structure, high quality protein...



Cellular Integration of Signalling Pathways in Plant Development (Nato a S I Series Series H, Cell Biology)
by Italy) NATO Advanced Study Institute on Plant Cell and Molecular Biology (8th : 1997 : Acquafredda di Maratea



Signalling Pathways in Apoptosis (Modern Genetics , Vol 5)
by Diane Watters, Martin Lavin

Apoptosis, or programmed cell death, is a necessary process by which a cell may die without adversely affecting its environment. It plays a crucial role in normal development, and in the body's defence mechanisms against disease. Too much cell death is destructive, leading to neurodegenerative diseases and impaired development. Conversely, too little cell death can lead to an increased...



Cell Apoptotic Signalling Pathways

The sexual differentiation pathway in Physarum polycephalum (Massachusetts Institute of Technology. Dept. of Biology. Thesis. 1977. Ph. D)
by YV?onne Regina Jones-Brown

© 2008 BrightSurf.com